Search research articles
Contact Us
Filters
Showing results (131-140 of 215) with videos related to
Page
of 22
Sort By:
The Journal of Antimicrobial Chemotherapy
|
April 1, 1996
In-vitro and in-vivo antibacterial activity of LB10517, a novel catechol-substituted cephalosporin with a broad antibacterial spectrum
H K Song, J I Oh, M Y Kim, et al.
The Korean Journal of Parasitology
|
September 1, 1994
[Occurrence of tertian malaria in a male patient who has never been abroad]
I H Chai, G I Lim, S N Yoon, et al.
Biochemical and Biophysical Research Communications
|
March 6, 2007
Interferon-gamma and NF-kappaB mediate nitric oxide production by mesenchymal stromal cells
I Oh, K Ozaki, K Sato, et al.
Psychiatry Research
|
September 30, 2018
Longitudinal associations between 4-hydroxynonenal and depression in coronary artery disease patients
Michael Rosen, Parco Chan, Mahwesh Saleem, et al.
The Journal of Clinical Psychiatry
|
January 7, 2011
Major depressive disorder predicts completion, adherence, and outcomes in cardiac rehabilitation: a prospective cohort study of 195 patients with coronary artery disease
Walter Swardfager, Nathan Herrmann, Susan Marzolini, et al.
Cardiovascular Psychiatry and Neurology
|
December 13, 2017
Baseline Oxidative Stress Is Associated with Memory Changes in Omega-3 Fatty Acid Treated Coronary Artery Disease Patients
Graham Mazereeuw, Nathan Herrmann, Ana C Andreazza, et al.
Bone Marrow Transplantation
|
September 1, 2009
IL-21 is critical for GVHD in a mouse model
A Meguro, K Ozaki, I Oh, et al.
Brain, Behavior, and Immunity
|
October 16, 2016
Oxidative stress predicts depressive symptom changes with omega-3 fatty acid treatment in coronary artery disease patients
Graham Mazereeuw, Nathan Herrmann, Ana C Andreazza, et al.
Journal of Clinical Psychopharmacology
|
August 17, 2016
Omega-3 Fatty Acids, Depressive Symptoms, and Cognitive Performance in Patients With Coronary Artery Disease: Analyses From a Randomized, Double-Blind, Placebo-Controlled Trial
Graham Mazereeuw, Nathan Herrmann, Paul I Oh, et al.
Neuropsychiatric Disease and Treatment
|
September 22, 2010
Relationship between hair cortisol concentrations and depressive symptoms in patients with coronary artery disease
Yekta Dowlati, Nathan Herrmann, Walter Swardfager, et al.
Page
of 22
Search research articles
Search
Showing results (131-140 of 215) with videos related to
Sort By:
Page
of 22
The Journal of Antimicrobial Chemotherapy
|
April 1, 1996
In-vitro and in-vivo antibacterial activity of LB10517, a novel catechol-substituted cephalosporin with a broad antibacterial spectrum
H K Song, J I Oh, M Y Kim, et al.
The Korean Journal of Parasitology
|
September 1, 1994
[Occurrence of tertian malaria in a male patient who has never been abroad]
I H Chai, G I Lim, S N Yoon, et al.
Biochemical and Biophysical Research Communications
|
March 6, 2007
Interferon-gamma and NF-kappaB mediate nitric oxide production by mesenchymal stromal cells
I Oh, K Ozaki, K Sato, et al.
Psychiatry Research
|
September 30, 2018
Longitudinal associations between 4-hydroxynonenal and depression in coronary artery disease patients
Michael Rosen, Parco Chan, Mahwesh Saleem, et al.
The Journal of Clinical Psychiatry
|
January 7, 2011
Major depressive disorder predicts completion, adherence, and outcomes in cardiac rehabilitation: a prospective cohort study of 195 patients with coronary artery disease
Walter Swardfager, Nathan Herrmann, Susan Marzolini, et al.
Cardiovascular Psychiatry and Neurology
|
December 13, 2017
Baseline Oxidative Stress Is Associated with Memory Changes in Omega-3 Fatty Acid Treated Coronary Artery Disease Patients
Graham Mazereeuw, Nathan Herrmann, Ana C Andreazza, et al.
Bone Marrow Transplantation
|
September 1, 2009
IL-21 is critical for GVHD in a mouse model
A Meguro, K Ozaki, I Oh, et al.
Brain, Behavior, and Immunity
|
October 16, 2016
Oxidative stress predicts depressive symptom changes with omega-3 fatty acid treatment in coronary artery disease patients
Graham Mazereeuw, Nathan Herrmann, Ana C Andreazza, et al.
Journal of Clinical Psychopharmacology
|
August 17, 2016
Omega-3 Fatty Acids, Depressive Symptoms, and Cognitive Performance in Patients With Coronary Artery Disease: Analyses From a Randomized, Double-Blind, Placebo-Controlled Trial
Graham Mazereeuw, Nathan Herrmann, Paul I Oh, et al.
Neuropsychiatric Disease and Treatment
|
September 22, 2010
Relationship between hair cortisol concentrations and depressive symptoms in patients with coronary artery disease
Yekta Dowlati, Nathan Herrmann, Walter Swardfager, et al.
Page
of 22